Housing Boosts Home...
Health Care: Drugs
Titan Pharmaceuticals Incorporated (TTNP: OTC)
$0.54 -0.01 | -1.82%
05/21/13 - 02:44 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2007 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 18.10M | 5.41M | 3.18M | 25.61M |
| Receivables | 4.65M | 3.72M | 1.22M | 0.00 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 23.44M | 9.96M | 4.70M | 30.46M |
| Property, Plant & Equipment, Gross | 3.84M | 2.68M | 2.59M | 2.52M |
| Accumulated Depreciation & Depletion | 2.45M | 2.43M | 2.54M | 2.13M |
| Property, Plant & Equipment, Net | 1.39M | 255.00K | 53.00K | 388.00K |
| Intangibles | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Assets | 1.39M | 255.00K | 53.00K | 388.00K |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 24.83M | 10.22M | 4.75M | 30.84M |
| Accounts Payable | 3.77M | 4.79M | 2.46M | 557.00K |
| Short Term Debt | 2.50M | 0.00 | 1.87M | 0.00 |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 21.39M | 5.12M | 5.40M | 4.26M |
| Long Term Debt | 9.36M | 12.25M | 5.40M | 0.00 |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 17.20M | 12.92M | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 26.56M | 25.17M | 5.40M | 1.24M |
| Total Liabilities | 47.96M | 30.30M | 10.80M | 5.50M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | -23.13M | -20.08M | -6.05M | 25.35M |
| Common Par | 265.99M | 256.44M | 256.44M | 255.43M |
| Additional Paid In Capital | 21.01M | 18.43M | 17.26M | 11.51M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -310.13M | -294.95M | -279.74M | -241.59M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 0.00 | 0.00 | 0.00 | 1.00K |
| Total Capitalization | -13.77M | -7.83M | -653.00K | 25.35M |
| Total Equity | -23.13M | -20.08M | -6.05M | 25.35M |
| Total Liabilities & Stock Equity | 24.83M | 10.22M | 4.75M | 30.84M |
| Total Common Shares Outstanding | 75.22M | 59.39M | 59.25M | 58.28M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 66.51M | 59.32M | 59.25M | 43.00M |
| Diluted Weighted Shares Outstanding | 66.51M | 59.32M | 59.25M | 43.00M |
| Number of Employees | 13 | 12 | 8 | 44 |
| Number of Part-Time Employees | 2 | 0 | 3 | 0 |
Portfolios with TTNP
- Portfolio NameUser Type
- UserJKE 1
Latest TTNP Headlines from TheStreet
- FDA Rejection of Titan's Probuphine Looks Like a Mugging 05.01.13 | 05:05 am
- Biotech Stock Mailbag: Exact Sciences, Galena, Titan, Arena, Breakthrough Therapy 04.12.13 | 06:04 am
- Titan Pharma: FDA Panel Live Blog 03.21.13 | 07:03 am
- The Next Big Thing In Biotech: Titan
03.14.13 | 12:03 pm - Best And Worst FDA Drug Approval Stocks of 2013 03.12.13 | 08:03 am
- Play TheStreet's FDA Drug Approval Contest 03.05.13 | 12:03 pm
- Biotech Stock Mailbag: Northwest Bio, Amarin, Titan Pharma 02.15.13 | 06:02 am
- Titan Pharma: Run-Up Trade Into March FDA Panel 01.31.13 | 06:01 am
Press Releases for TTNP
- Top Stocks On The Move: Medi Swipe Inc., New Western Energy Corp., Titan Pharmaceuticals Inc., And Advanced Cell Technology Inc. - PR Newswire 01.07.13 | 09:01 am
- Titan Reports Fourth Quarter 2010 Fanapt® Royalty - PR Newswire 02.03.11 | 09:02 pm
Partner Headlines for TTNP
